[1] |
Zhao D, Liu J, Wang M , et al. Epidemiology of cardiovascular disease in China: current features and implications[J]. Nature Reviews Cardiology, 2019,16:203-212.
doi: 10.1038/s41569-018-0119-4
pmid: 30467329
|
[2] |
Park S J, Kang S J, Virmani R , et al. In-stent neoatherosclerosis: a final common pathway of late stent failure[J]. Journal of the American College of Cardiology, 2012,59:2051-2057.
doi: 10.1016/j.jacc.2011.10.909
|
[3] |
Adriaenssens T, Joner M, Godschalk T C , et al. Optical coherence tomography findings in patients with coronary stent thrombosis: a report of the PRESTIGE consortium (prevention of late stent thrombosis by an interdisciplinary global european effort)[J]. Circulation, 2017,136:1007-1021.
doi: 10.1161/CIRCULATIONAHA.117.026788
pmid: 28720725
|
[4] |
Kang S J, Mintz G S, Park D W , et al. Tissue characterization of in-stent neointima using intravascular ultrasound radiofrequency data analysis[J]. The American Journal of Cardiology, 2010,106:1561-1565.
doi: 10.1016/j.amjcard.2010.07.031
pmid: 21094355
|
[5] |
Nakazawa G, Otsuka F, Nakano M , et al. The pathology of neoatherosclerosis in human coronary implants bare-metal and drug-eluting stents[J]. Journal of the American College of Cardiology, 2011,57:1314-1322.
doi: 10.1016/j.jacc.2011.01.011
|
[6] |
Higo T, Ueda Y, Oyabu J , et al. Atherosclerotic and thrombogenic neointima formed over sirolimus drug-eluting stent: an angioscopic study[J]. JACC Cardiovascular Imaging, 2009,2(5):616-624.
doi: 10.1016/j.jcmg.2008.12.026
pmid: 19442950
|
[7] |
Otsuka F, Byrne R A, Yahagi K , et al. Neoatherosclerosis: overview of histopathologic findings and implications for intravascular imaging assessment[J]. European Heart Journal, 2015,36:2147-2159.
doi: 10.1093/eurheartj/ehv205
pmid: 25994755
|
[8] |
Yahagi K, Kolodgie F D, Otsuka F , et al. Pathophysiology of native coronary, vein graft, and in-stent atherosclerosis[J]. Nature Reviews Cardiology, 2016,13:79-98.
doi: 10.1038/nrcardio.2015.164
pmid: 26503410
|
[9] |
Lee C W, Kang S J, Park D W , et al. Intravascular ultrasound findings in patients with very late stent thrombosis after either drug-eluting or bare-metal stent implantation[J]. Journal of the American College of Cardiology, 2010,55:1936-1942.
doi: 10.1016/j.jacc.2009.11.088
pmid: 20430265
|
[10] |
Finn A V, Otsuka F . Neoatherosclerosis: a culprit in very late stent thrombosis[J]. Circulation Cardiovascular Interventions, 2012,5:6-9.
doi: 10.1161/CIRCINTERVENTIONS.111.967927
pmid: 22338000
|
[11] |
Warboys C M, De Luca A, Amini N , et al. Disturbed flow promotes endothelial senescence via a p53-dependent pathway[J]. Arteriosclerosis, Thrombosis, and Vascular Biology, 2014,34:985-995.
doi: 10.1161/ATVBAHA.114.303415
pmid: 24651677
|
[12] |
Kimura T, Yokoi H, Nakagawa Y , et al. Three-year follow-up after implantation of metallic coronary-artery stents[J]. The New England Journal of Medicine, 1996,334:561-566.
doi: 10.1056/NEJM199602293340903
pmid: 8569823
|
[13] |
Chen M S, John J M, Chew D P , et al. Bare metal stent restenosis is not a benign clinical entity[J]. American Heart Journal, 2006,151:1260-1264.
doi: 10.1016/j.ahj.2005.08.011
pmid: 16781233
|
[14] |
Kimura T, Abe K, Shizuta S , et al. Long-term clinical and angiographic follow-up after coronary stent placement in native coronary arteries[J]. Circulation, 2002,105:2986-2991.
doi: 10.1161/01.cir.0000019743.11941.3b
pmid: 12081992
|
[15] |
Yokoyama S, Takano M, Yamamoto M , et al. Extended follow-up by serial angioscopic observation for bare-metal stents in native coronary arteries: from healing response to atherosclerotic transformation of neointima[J]. Circulation Cardiovascular Interventions, 2009,2:205-212.
doi: 10.1161/CIRCINTERVENTIONS.109.854679
pmid: 20031717
|
[16] |
Natsuaki M, Morimoto T, Furukawa Y , et al. Late adverse events after implantation of sirolimus-eluting stent and bare-metal stent: long-term (5-7 years) follow-up of the Coronary Revascularization Demonstrating Outcome study-Kyoto registry Cohort-2[J]. Circulation Cardiovascular Interventions, 2014,7(2):168-179.
doi: 10.1161/CIRCINTERVENTIONS.113.000987
pmid: 24550439
|
[17] |
Grube E, Dawkins K, Guagliumi G , et al. TAXUS Ⅵfinal 5-year results: a multicentre, randomised trial comparing polymer-based moderate-release paclitaxel-eluting stent with a bare metal stent for treatment of long, complex coronary artery lesions[J]. EuroIntervention: Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2009,4:572-577.
doi: 10.4244/EIJV4I5A97
|
[18] |
Kang S J, Park D W, Mintz G S , et al. Long-term vascular changes after drug-eluting stent implantation assessed by serial volumetric intravascular ultrasound analysis[J]. The American Journal of Cardiology, 2010,105:1402-1408.
doi: 10.1016/j.amjcard.2009.12.064
pmid: 20451685
|
[19] |
Nakazawa G, Vorpahl M, Finn A V , et al. One step forward and two steps back with drug-eluting-stents: from preventing restenosis to causing late thrombosis and nouveau atherosclerosis[J]. JACC Cardiovascular Imaging, 2009,2:625-628.
doi: 10.1016/j.jcmg.2009.01.011
pmid: 19442951
|
[20] |
Romero M E, Yahagi K, Kolodgie F D , et al. Neoatherosclerosis from a pathologist's point of view[J]. Arteriosclerosis, Thrombosis, and Vascular Biology, 2015,35:e43-e49.
doi: 10.1161/ATVBAHA.115.306251
pmid: 26399921
|
[21] |
Otsuka F, Vorpahl M, Nakano M , et al. Pathology of second-generation everolimus-eluting stents versus first-generation sirolimus- and paclitaxel-eluting stents in humans[J]. Circulation, 2014,129:211-223.
doi: 10.1161/CIRCULATIONAHA.113.001790
|
[22] |
Yonetsu T, Kato K, Kim S J , et al. Predictors for neoatherosclerosis: a retrospective observational study from the optical coherence tomography registry[J]. Circulation Cardiovascular Imaging, 2012,5:660-666.
doi: 10.1161/CIRCIMAGING.112.976167
pmid: 22798521
|
[23] |
Gomez-Lara J, Brugaletta S, Jacobi F , et al. Five-year optical coherence tomography in patients with ST-segment-elevation myocardial infarction treated with bare-metal versus everolimus-eluting stents[J]. Circulation Cardiovascular Interventions, 2016,9(10):e003670.
doi: 10.1161/CIRCINTERVENTIONS.116.003670
pmid: 27702766
|
[24] |
Taniwaki M, Windecker S, Zaugg S , et al. The association between in-stent neoatherosclerosis and native coronary artery disease progression: a long-term angiographic and optical coherence tomography cohort study[J]. European Heart Journal, 2015,36:2167-2176.
doi: 10.1093/eurheartj/ehv227
pmid: 26040806
|
[25] |
Habara M, Terashima M, Nasu K , et al. Difference of tissue characteristics between early and very late restenosis lesions after bare-metal stent implantation: an optical coherence tomography study[J]. Circulation Cardiovascular Interventions, 2011,4:232-238.
doi: 10.1161/CIRCINTERVENTIONS.110.959999
pmid: 21610225
|
[26] |
Takano M, Yamamoto M, Inami S , et al. Appearance of lipid-laden intima and neovascularization after implantation of bare-metal stents extended late-phase observation by intracoronary optical coherence tomography[J]. Journal of the American College of Cardiology, 2009,55:26-32.
doi: 10.1016/j.jacc.2009.08.032
pmid: 20117359
|
[27] |
Kang S J, Mintz G S, Akasaka T , et al. Optical coherence tomographic analysis of in-stent neoatherosclerosis after drug-eluting stent implantation[J]. Circulation, 2011,123:2954-2963.
doi: 10.1161/CIRCULATIONAHA.110.988436
|
[28] |
Raber L, Serruys P W . Late vascular response following drug-eluting stent implantation[J]. JACC Cardiovascular Interventions, 2011,4:1075-1078.
doi: 10.1016/j.jcin.2011.06.016
pmid: 22017931
|
[29] |
Joner M, Nakazawa G, Finn A V , et al. Endothelial cell recovery between comparator polymer-based drug-eluting stents[J]. Journal of the American College of Cardiology, 2008,52:333-342.
doi: 10.1016/j.jacc.2008.04.030
|
[30] |
Torii R, Stettler R, Raber L , et al. Implications of the local hemodynamic forces on the formation and destabilization of neoatherosclerotic lesions[J]. International Journal of Cardiology, 2018,272:7-12.
doi: 10.1016/j.ijcard.2018.06.065
pmid: 30293579
|